Immediate hypersensitivity reaction following liposomal amphotericin-B (AmBisome) infusion

Liposomal amphotericin-B (AmBisome) is now becoming first choice for the treatment of visceral leishmaniasis (kala-azar) patients due to high efficacy and less toxicity. The reported incidence of hypersensitivity reactions to liposomal amphotericin-B (AmBisome), especially during therapy, is very ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Nath, Proggananda, Basher, Ariful, Harada, Michiyo, Sarkar, Santana, Selim, Shahjada, Maude, Richard J, Noiri, Eisei, Faiz, Abul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2014
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232346/
https://www.ncbi.nlm.nih.gov/pubmed/25139411
http://dx.doi.org/10.1177/0049475514543655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232346/
https://www.ncbi.nlm.nih.gov/pubmed/25139411
http://dx.doi.org/10.1177/0049475514543655

Ejemplares similares